(Total Views: 330)
Posted On: 02/23/2020 6:42:33 PM
Post# of 72446
No, I wasn't suggesting that and I did not write that.
I wrote:
I picked an extremely large upfront payment on a structured partnership or buyout that I thought AS would be unwilling to match.
I don't have any clue how any big pharma company values Brilacidin. I'm comfortable assuming the upfront payment on any deal will not exceed $500 million unless we do a large and very successful B-UC phase 2. With our current results I would guess full take-out on Brilacidin would be $500 million to $1 billion.
$1 billion is a lot of money to lay on the table. I think any deal will be structured with milestones for that reason.
I wrote:
Quote:
A Pfizer could write a check for $500 million or more upfront
I picked an extremely large upfront payment on a structured partnership or buyout that I thought AS would be unwilling to match.
I don't have any clue how any big pharma company values Brilacidin. I'm comfortable assuming the upfront payment on any deal will not exceed $500 million unless we do a large and very successful B-UC phase 2. With our current results I would guess full take-out on Brilacidin would be $500 million to $1 billion.
$1 billion is a lot of money to lay on the table. I think any deal will be structured with milestones for that reason.
(1)
(0)
